XML 39 R24.htm IDEA: XBRL DOCUMENT v3.20.1
Earnings Per Share (Tables)
 3 Months Ended
Mar. 31, 2020
Earnings Per Share [Abstract]  
Schedule of Earnings Per Share, Basic and Diluted
A reconciliation of the numerator and denominator of basic and diluted earnings per share follows (dollars in millions, except per share amounts; shares in thousands):
 
Three Months Ended March 31,
 
2020
 
2019
Numerator:
 
 
 
Net loss attributable to Surgery Partners, Inc.
$
(27.5
)
 
$
(20.1
)
Less: amounts allocated to participating securities (1)
(9.5
)
 
(8.5
)
Net loss attributable to common stockholders
$
(37.0
)
 
$
(28.6
)
 
 
 
 
Denominator:
 
 
 
Weighted average shares outstanding- basic and diluted (2)
48,472

 
48,047

 
 
 
 
Loss per share:
 
 
 
Basic and diluted (2)
$
(0.76
)
 
$
(0.60
)
 
 
 
 
Dilutive securities outstanding not included in the computation of loss per share as their effect is antidilutive:
 
 
 
Stock options
72

 
—

Restricted shares
298

 
18

(1)
Includes dividends accrued during all periods for the Series A Preferred Stock. The Series A Preferred Stock does not participate in undistributed losses.
(2)
The impact of potentially dilutive securities for all periods presented was not considered because the effect would be anti-dilutive in each period.